Variant report
Variant | nsv606040 |
---|---|
Chromosome Location | chr7:7330622-7336294 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:45)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:45 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr7:7332331-7332638 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr7:7332303-7332671 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr7:7332352-7332653 | K562 | blood: | n/a | n/a |
4 | CTCF | chr7:7330404-7330717 | K562 | blood: | n/a | chr7:7330546-7330556 |
5 | CTCF | chr7:7330474-7330630 | K562 | blood: | n/a | chr7:7330546-7330556 |
6 | CTCF | chr7:7330520-7330670 | Caco-2 | colon: | n/a | chr7:7330546-7330556 |
7 | CTCF | chr7:7330486-7330636 | HepG2 | liver: | n/a | chr7:7330546-7330556 |
8 | CTCF | chr7:7330502-7330676 | GM12878 | blood: | n/a | chr7:7330546-7330556 |
9 | CTCF | chr7:7330497-7330622 | Hela-S3 | cervix: | n/a | chr7:7330546-7330556 |
10 | CTCF | chr7:7330352-7330746 | MCF-7 | breast: | n/a | chr7:7330546-7330556 |
11 | EP300 | chr7:7332488-7332505 | K562 | blood: | n/a | n/a |
12 | FOXA2 | chr7:7334637-7334865 | HepG2 | liver: | n/a | n/a |
13 | GATA3 | chr7:7330304-7330768 | MCF-7 | breast: | n/a | n/a |
14 | GATA3 | chr7:7330424-7330676 | MCF-7 | breast: | n/a | n/a |
15 | HNF4A | chr7:7334685-7334902 | HepG2 | liver: | n/a | chr7:7334763-7334775 chr7:7334762-7334777 chr7:7334762-7334775 chr7:7334762-7334776 chr7:7334762-7334777 chr7:7334762-7334775 chr7:7334762-7334777 chr7:7334762-7334776 chr7:7334760-7334778 chr7:7334764-7334776 chr7:7334763-7334775 chr7:7334763-7334775 chr7:7334762-7334775 chr7:7334762-7334777 chr7:7334763-7334776 chr7:7334763-7334775 chr7:7334762-7334777 chr7:7334762-7334776 |
16 | HNF4A | chr7:7334605-7334876 | HepG2 | liver: | n/a | chr7:7334763-7334775 chr7:7334762-7334777 chr7:7334762-7334775 chr7:7334762-7334776 chr7:7334762-7334777 chr7:7334627-7334640 chr7:7334762-7334775 chr7:7334762-7334777 chr7:7334762-7334776 chr7:7334760-7334778 chr7:7334764-7334776 chr7:7334627-7334640 chr7:7334763-7334775 chr7:7334763-7334775 chr7:7334762-7334775 chr7:7334762-7334777 chr7:7334763-7334776 chr7:7334763-7334775 chr7:7334762-7334777 chr7:7334762-7334776 |
17 | JUND | chr7:7332389-7332503 | K562 | blood: | n/a | n/a |
18 | MAFF | chr7:7332472-7332501 | K562 | blood: | n/a | n/a |
19 | MAFK | chr7:7334976-7335075 | HepG2 | liver: | n/a | chr7:7334998-7335015 |
20 | MAFK | chr7:7334972-7335155 | HepG2 | liver: | n/a | chr7:7334998-7335015 |
21 | MAX | chr7:7331519-7331661 | K562 | blood: | n/a | n/a |
22 | MAX | chr7:7332328-7332665 | K562 | blood: | n/a | n/a |
23 | MAZ | chr7:7332328-7332546 | K562 | blood: | n/a | n/a |
24 | MYC | chr7:7332430-7332482 | MCF-7 | breast: | n/a | n/a |
25 | MYC | chr7:7332403-7332638 | K562 | blood: | n/a | n/a |
26 | MYC | chr7:7332376-7332631 | K562 | blood: | n/a | n/a |
27 | NR2F2 | chr7:7330359-7330863 | MCF-7 | breast: | n/a | n/a |
28 | NR2F2 | chr7:7330381-7330689 | HepG2 | liver: | n/a | n/a |
29 | NR2F2 | chr7:7330402-7330770 | MCF-7 | breast: | n/a | n/a |
30 | NR2F2 | chr7:7330356-7330712 | K562 | blood: | n/a | n/a |
31 | POLR2A | chr7:7331918-7331972 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr7:7336140-7336145 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr7:7334852-7335044 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | RAD21 | chr7:7330358-7330759 | HepG2 | liver: | n/a | chr7:7330544-7330557 |
35 | RAD21 | chr7:7330422-7330690 | Hela-S3 | cervix: | n/a | chr7:7330544-7330557 |
36 | RAD21 | chr7:7330423-7330651 | HepG2 | liver: | n/a | chr7:7330544-7330557 |
37 | RAD21 | chr7:7330446-7330668 | HepG2 | liver: | n/a | chr7:7330544-7330557 |
38 | RCOR1 | chr7:7332369-7332615 | K562 | blood: | n/a | n/a |
39 | SMC3 | chr7:7330413-7330696 | HepG2 | liver: | n/a | chr7:7330545-7330559 |
40 | SMC3 | chr7:7330454-7330626 | Hela-S3 | cervix: | n/a | chr7:7330545-7330559 |
41 | TAL1 | chr7:7331649-7331865 | K562 | blood: | n/a | n/a |
42 | TAL1 | chr7:7332421-7332604 | K562 | blood: | n/a | n/a |
43 | UBTF | chr7:7332518-7332529 | K562 | blood: | n/a | n/a |
44 | YY1 | chr7:7331780-7331981 | GM12892 | blood: | n/a | n/a |
45 | ZNF143 | chr7:7331530-7331658 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C1GALT1-3 | chr7:7333139-7333511 | NONHSAT119110 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236712 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7784370 | chr7:7330622-7330623 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs192429469 | chr7:7330627-7330628 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs557854482 | chr7:7330643-7330644 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs10275594 | chr7:7330661-7330662 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs543549843 | chr7:7330678-7330679 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs576887495 | chr7:7330692-7330693 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs562215099 | chr7:7330693-7330694 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs529469883 | chr7:7330715-7330716 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs184797801 | chr7:7330720-7330721 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs541660935 | chr7:7330734-7330735 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs560405627 | chr7:7330771-7330772 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs544202486 | chr7:7330773-7330774 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs560016118 | chr7:7330786-7330787 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs533651988 | chr7:7330838-7330839 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs189409632 | chr7:7330845-7330846 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs569546317 | chr7:7330866-7330867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566108744 | chr7:7330915-7330916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530528016 | chr7:7330919-7330920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548761307 | chr7:7330922-7330923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192588652 | chr7:7330935-7330936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562588017 | chr7:7330940-7330941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529774858 | chr7:7330964-7330965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10275950 | chr7:7330965-7330966 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs372534031 | chr7:7330975-7330976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552730705 | chr7:7331015-7331016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10276061 | chr7:7331043-7331044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113688358 | chr7:7331063-7331064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540763097 | chr7:7331073-7331074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151092991 | chr7:7331078-7331079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377480218 | chr7:7331082-7331083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538548713 | chr7:7331153-7331154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189656462 | chr7:7331188-7331189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73339367 | chr7:7331191-7331192 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs181451502 | chr7:7331206-7331207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370089263 | chr7:7331213-7331214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543810543 | chr7:7331217-7331218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555544067 | chr7:7331227-7331228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528815799 | chr7:7331270-7331271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546955619 | chr7:7331271-7331272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574203723 | chr7:7331374-7331375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186049217 | chr7:7331387-7331388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62450790 | chr7:7331390-7331391 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs578236303 | chr7:7331420-7331421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189215634 | chr7:7331425-7331426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564016142 | chr7:7331447-7331448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112093154 | chr7:7331457-7331458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181863243 | chr7:7331461-7331462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560575253 | chr7:7331465-7331466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186357588 | chr7:7331545-7331546 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs546332949 | chr7:7331551-7331552 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:7320000-7332000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr7:7322600-7332200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr7:7329800-7330800 | Enhancers | HepG2 | liver |
4 | chr7:7329800-7335000 | Enhancers | Liver | Liver |
5 | chr7:7331400-7332000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr7:7331400-7332200 | Enhancers | K562 | blood |
7 | chr7:7331400-7335200 | Enhancers | Fetal Intestine Large | intestine |
8 | chr7:7331600-7332000 | Enhancers | GM12878-XiMat | blood |
9 | chr7:7331800-7332800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:7332000-7332400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr7:7332200-7332400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr7:7332200-7332400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr7:7332200-7332600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr7:7332200-7332600 | Enhancers | Pancreas | Pancrea |
15 | chr7:7332200-7333200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr7:7332200-7333200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr7:7332200-7333200 | Enhancers | Placenta | Placenta |
18 | chr7:7332400-7333400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
19 | chr7:7332600-7335000 | Enhancers | Fetal Intestine Small | intestine |
20 | chr7:7332800-7334200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr7:7333200-7333600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr7:7333400-7333800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
23 | chr7:7333400-7334200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
24 | chr7:7334400-7335000 | Enhancers | HepG2 | liver |
25 | chr7:7335000-7335800 | Weak transcription | Fetal Intestine Small | intestine |
26 | chr7:7335800-7336000 | Enhancers | Fetal Intestine Small | intestine |